Blog: Research

MS Progression Affected by Degree of Relapse Recovery and Timing of DMT Use, Study Says

21 January 2020

Source Multiple Sclerosis News Today: Recovering well after a first relapse and starting a disease-modifying therapy (DMT) immediately afterwards considerably increases the likelihood of slowing progression in multiple sclerosis (MS), a study suggests.

Its findings support relapse recovery as a critical factor for DMT initiation, and one that should be assessed routinely in MS clinical trials, researchers said.

The study, “Relapse recovery: The forgotten variable in multiple...

New Study Asks: When Does MS Begin?

21 January 2020

Source National Multiple Sclerosis Society: Researchers from the Harvard T.H. Chan School of Public Health in Boston and collaborators report on a study that examined blood (serum) samples from 60 military personnel who went on to develop multiple sclerosis years later. Compared to samples from a control group, those who eventually developed MS showed higher than usual levels of a molecule (neurofilament light chain - NfL) that reflects damage to the nervous system.

The levels of NfL...

The MS Society is excited to announce their 13 new MS research projects

17 December 2019

Source MS Society: Virtual reality, wearable robots and magnetic brain stimulation. Technology is at the forefront of 13 new research projects we've just announced.

Cannabis-based medicines: Two drugs approved for NHS

11 November 2019

Source BBC: Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.

European drug regulator recommends restricted use of Lemtrada

11 November 2019

Source MS Trust: Lemtrada (alemtuzumab) should be restricted to people with highly active relapsing-remitting MS according to a review carried out by the European Medicines Agency's (EMA) drug safety committee.

Sativex cost-effective in final NICE guideline on cannabis-based medicines

11 November 2019

Source MS Trust: Sativex is a cost-effective treatment for people with MS spasticity according to new guidance published today by NICE(link is external). This reverses the decision made in draft guidance published earlier this year.

Immersion in virtual reality scenes of the Arctic helps to ease people's pain

11 November 2019

Source Medical Xpress: Watching immersive 360 videos of icy Arctic scenes helps to relieve intense burning pain and could hold hope for treating chronic pain, a small study has found.

Can standing frames improve mobility in progressive MS?

25 October 2019

Source MS Trust: This study set out to test the benefits of regular home-based standing combined with strengthening and balance exercises for people with progressive MS.

People with progressive MS with severe walking problems (122 people) were recruited through NHS clinics and therapy centres in Devon, Cornwall and East Anglia. One half were assigned to the standing frame group in addition to their standard care, the other half continued with standard care alone for 20 weeks....

The MS research that's offering me hope

8 October 2019

Source BBC: "I don't like to think of the future. It's such a big question mark. I just keep living in the present."Source BBC: "I don't like to think of the future. It's such a big question mark. I just keep living in the present."

Diabetes drug offers hope of new treatment for multiple sclerosis.

7 October 2019

Source The Guardian: Trial using rats showed the drug metformin repaired nerve damage caused by the disease.

Pages

Category

Archive